Skip to main content
Clinical Trials/NCT00938951
NCT00938951CompletedNot Applicable

Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

Alcon Research0 sites16 target enrollmentStarted: June 1, 2009Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
16
Primary Endpoint
Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session

Study Overview

Brief Summary

The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Player/ Coach must answer "Yes" to the survey eligibility question.
  • •Player/Coach must voluntarily agree to participate in survey

Exclusion Criteria

  • Not provided

Arms & Interventions

Systane® Ultra

Experimental

Systane® Ultra

Intervention: Systane® Ultra (Other)

Outcomes

Primary Outcomes

Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session

Time Frame: 60 minutes post-dosing with test article

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials